Cables

BioNTech ve ‘muy probable’ que su vacuna responda a mutación del coronavirus

Cofundador del laboratorio alemán afirma que podría suministrar una inyección adaptada a la nueva cepa del virus registrada en el Reino Unido ‘en seis semanas’

Head of Nursing Helen Raine at the Haxby and Wigginton Group Medical Practice poses for a photograph with a vial of the Pfizer-BioNTech Covid-19 vaccine, in Haxby, northern England on December 22, 2020. - Europe is expected to start a massive vaccination campaign after Christmas following the United States and Britain, which have begun giving jabs with an approved Pfizer-BioNTech shot, one of several leading candidates. (Photo by Lindsey Parnaby / AFP)
Head of Nursing Helen Raine at the Haxby and Wigginton Group Medical Practice poses for a photograph with a vial of the Pfizer-BioNTech Covid-19 vaccine, in Haxby, northern England on December 22, 2020. - Europe is expected to start a massive vaccination campaign after Christmas following the United States and Britain, which have begun giving jabs with an approved Pfizer-BioNTech shot, one of several leading candidates. (Photo by Lindsey Parnaby / AFP) LINDSEY PARNABY
‌
‌

‌

‌
‌

‌

‌